J.W. Cole Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-857
Closed -$212K – 1632
2026
Q2
$212K Buy
+857
New +$185K ﹤0.01% 1479
2026
Q1
– Sell
-1,074
Closed -$222K – 970
2025
Q4
$222K Sell
1,074
-57
-5% -$11.4K 0.01% 1251
2025
Q3
$203K Buy
+1,131
New +$193K ﹤0.01% 1434
2025
Q2
– Sell
-1,193
Closed -$203K – 1470
2025
Q1
$203K Buy
+1,193
New +$207K 0.01% 1153
2024
Q4
– Sell
-1,183
Closed -$203K – 973
2024
Q3
$203K Buy
+1,183
New +$196K 0.01% 903
2024
Q1
– Sell
-1,310
Closed -$207K – 892
2023
Q4
$207K Buy
+1,310
New +$188K 0.01% 754
2021
Q2
– Sell
-1,541
Closed -$247K – 746
2021
Q1
$247K Buy
+1,541
New +$264K 0.02% 574

Other funds holding FBT

J.W. Cole Advisors's FBT Position: Q3 2026 in Review

J.W. Cole Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 857 shares — an estimated $212K sold.

J.W. Cole Advisors first reported a position in FBT in Q1 2021 and held it in 7 quarters. The position peaked at $247K in Q1 2021. 350 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • J.W. Cole Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
  • J.W. Cole Advisors sold 857 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $212K.
  • J.W. Cole Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2021 and held it in 7 quarters.
  • J.W. Cole Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $247K in Q1 2021.
  • 350 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on J.W. Cole Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.